Profil
Thomas X.
Neenan is the founder of Sideris Pharmaceuticals, Inc. as Chief Executive & Technology Officer, founded in 2012.
Dr. Neenan was the founder of Panbela Therapeutics, Inc. as Chief Scientific Officer, founded in 2011.
Dr. Neenan is also the founder of AbFero Pharmaceuticals, Inc.,Excubio Pharmaceuticals, Inc. Former jobs include Director at NDFOS Co., Ltd., Vice President-New Ventures at GelTex Pharmaceuticals, Inc., Vice President-Business Operations at Genzyme Corp., Principal at Harvard University from 1985 to 1987, Vice President-Business Development at Trine Pharmaceuticals, Inc., Principal at Bell Laboratories, and Vice President-Business Development at Warwick Effect Polymers Ltd. Education includes a doctorate from Harvard University, a doctorate from The Pennsylvania State University conferred in 1985, and an undergraduate degree from National University of Ireland.
Postes actifs de Thomas Neenan
| Sociétés | Poste | Début |
|---|---|---|
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Fondateur | - |
Anciens postes connus de Thomas Neenan
| Sociétés | Poste | Fin |
|---|---|---|
| SUN BIOPHARMA INC | Fondateur | 01/06/2022 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | 19/09/2008 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1987 |
| NDFOS CO., LTD. | Directeur/Membre du Conseil | - |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload | Directeur Général | - |
Formation de Thomas Neenan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Bell Laboratories
Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
National University of Ireland
National University of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Designs and produces polymers synthesis | Process Industries |
Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
NDFOS Co., Ltd.
NDFOS Co., Ltd. Containers/PackagingProcess Industries Manufactures plastic films sheets and plates | Process Industries |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Health Technology |
















